6533b827fe1ef96bd128681b

RESEARCH PRODUCT

Diversity and dynamic changes of anelloviruses in plasma following allogeneic hematopoietic stem cell transplantation.

José Luis PiñanaEstela GiménezCarlos SolanoCarlos SolanoCarolina MonzóDavid NavarroAzahara Fuentes-trilloEliseo AlbertEnrique SedaJavier F ChavesJuan Carlos Hernández Boluda

subject

AdultMaleTorque teno virusAlphatorquevirusmedicine.medical_treatmentHematopoietic stem cell transplantationAnelloviridaeDNA sequencinglaw.invention03 medical and health sciencesPlasma0302 clinical medicinelawVirologymedicineTorque teno midi virusHumansTransplantation HomologousAnelloviridae030212 general & internal medicinePolymerase chain reactionAgedTorque teno mini virusbiologyHematopoietic Stem Cell TransplantationMiddle Agedbiology.organism_classificationVirologyDNA Virus Infectionssurgical procedures operativeInfectious DiseasesDNA Viral030211 gastroenterology & hepatologyFemale

description

Monitoring of alphatorquevirus (torque teno virus [TTV]) DNA in plasma may prove to be useful to assess the net state of immune competence following allogeneic hematopoietic stem cell transplantation (allo-HSCT). There are scarce data published on the prevalence of beta (torque teno mini virus [TTMV]) and gammatorqueviruses (torque teno midi virus [TTMDV]) and, in particular, on the dynamics of anelloviruses in allo-HSCT patients. Twenty-five allo-HSCT recipients with available plasma specimens obtained before conditioning and after engraftment were included. Degenerated primers targeting a highly conserved genomic sequence across all anelloviruses were designed for genomic amplification and high-throughput sequencing. Co-detection of TTV, TTMV, and TTMDV both in pre-transplant and post-engraftment plasma specimens was documented in more than two-thirds of patients. The use of quantitative real-time polymerase chain reaction (PCR) assays targeting TTMV and TTMDV in addition to TTV may add value to TTV-specific PCR assays in the inference of the net state of immunosuppresion or immune competence in this clinical setting.

10.1002/jmv.26661https://pubmed.ncbi.nlm.nih.gov/33174620